The Confusion Surrounding Androgen Deprivation Therapy and Cognitive Dysfunction.


Journal

European urology focus
ISSN: 2405-4569
Titre abrégé: Eur Urol Focus
Pays: Netherlands
ID NLM: 101665661

Informations de publication

Date de publication:
May 2023
Historique:
received: 13 01 2023
accepted: 08 03 2023
medline: 26 6 2023
pubmed: 3 4 2023
entrez: 2 4 2023
Statut: ppublish

Résumé

There are varied associations that have been identified between the use of androgen deprivation therapy (ADT) and the development of cognitive decline. We highlight the first studies to evaluate chronic use of ADT, other systemic treatments for prostate cancer, and genetic polymorphisms in this context.

Identifiants

pubmed: 37005166
pii: S2405-4569(23)00083-4
doi: 10.1016/j.euf.2023.03.015
pii:
doi:

Substances chimiques

Androgen Antagonists 0
Androgens 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

409-410

Informations de copyright

Copyright © 2023 European Association of Urology. Published by Elsevier B.V. All rights reserved.

Auteurs

Michael J Pierro (MJ)

Division of Hematology/Oncology, Department of Internal Medicine, Medical College of Wisconsin, Milwaukee, WI, USA. Electronic address: mpierro@mcw.edu.

Deepak Kilari (D)

Division of Hematology/Oncology, Department of Internal Medicine, Medical College of Wisconsin, Milwaukee, WI, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH